Cargando…

A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation

BACKGROUND: Endometrial cancer (EC) is a common malignancy of the female reproductive system worldwide. Increasing evidence has suggested that many transcription factors are aberrantly expressed in various cancers. This study aimed to develop a transcription factor-based prognostic signature for EC....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiao, Cheng, Yuan, Li, Xingchen, Zhou, Jingyi, Dong, Yangyang, Shen, Boqiang, Zhao, Lijun, Wang, Jianliu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053499/ https://www.ncbi.nlm.nih.gov/pubmed/33880037 http://dx.doi.org/10.2147/OTT.S293085

Ejemplares similares

Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2022)

Establishment and validation of a prognostic nomogram based on a novel five‐DNA methylation signature for survival in endometrial cancer patients
por: Li, Xingchen, et al.
Publicado: (2020)

An elevated preoperative serum calcium level is a significant predictor for positive peritoneal cytology in endometrial carcinoma
por: Li, Xingchen, et al.
Publicado: (2019)

Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients
por: Li, Xingchen, et al.
Publicado: (2023)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
por: Cheng, Yuan, et al.
Publicado: (2021)

Development and Validation of Nomograms Predicting the Overall and the Cancer-Specific Survival in Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2020)

Effects of Metabolic Syndrome and Its Components on the Prognosis of Endometrial Cancer
por: Yang, Xiao, et al.
Publicado: (2021)

Calcium and TRPV4 promote metastasis by regulating cytoskeleton through the RhoA/ROCK1 pathway in endometrial cancer
por: Li, Xingchen, et al.
Publicado: (2020)

Glutamine and amino acid metabolism as a prognostic signature and therapeutic target in endometrial cancer
por: Zhai, Lirong, et al.
Publicado: (2023)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

Estrogen-Induced Extracellular Calcium Influx Promotes Endometrial Cancer Progress by Regulating Lysosomal Activity and Mitochondrial ROS
por: Shen, Boqiang, et al.
Publicado: (2022)

Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes
por: Yang, Xiao, et al.
Publicado: (2022)

Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress
por: Zhou, Jingyi, et al.
Publicado: (2022)

The Ratio of Neutrophil to Lymphocyte is a Predictor in Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Development and Validation of a Nomogram Based on Metabolic Risk Score for Assessing Lymphovascular Space Invasion in Patients with Endometrial Cancer
por: Wang, Jingyuan, et al.
Publicado: (2022)

Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
por: Lin, Yanying, et al.
Publicado: (2018)

Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
por: Dai, Yibo, et al.
Publicado: (2019)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1
por: Yang, Yuan, et al.
Publicado: (2017)

Establishment of a novel cell cycle-related prognostic signature predicting prognosis in patients with endometrial cancer
por: Liu, Jinhui, et al.
Publicado: (2020)

Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: Zhou, Xin-Ying, et al.
Publicado: (2022)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

An Externally Validated Nomogram for Predicting Lymph Node Metastasis of Presumed Stage I and II Endometrial Cancer
por: Dong, Yangyang, et al.
Publicado: (2019)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
por: Ma, Yibo, et al.
Publicado: (2023)

Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation
por: Cheng, Yuan, et al.
Publicado: (2020)

Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: International, BioMed Research
Publicado: (2022)

Establishing a Prognostic Signature Based on Epithelial–Mesenchymal Transition-Related Genes for Endometrial Cancer Patients
por: Liu, Jinhui, et al.
Publicado: (2022)

Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
por: Yu, Jing, et al.
Publicado: (2022)

Heterogeneity of CD40 Expression in Different Types of High-Risk Endometrial Cancer Affects Discordant Prognostic Outcomes
por: Zhao, Na, et al.
Publicado: (2023)

Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention
por: Huang, Ting, et al.
Publicado: (2022)

A detailed analysis of lymph node recurrence in endometrial carcinoma
por: Li, He, et al.
Publicado: (2022)

Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma
por: Zhang, Xiangxin, et al.
Publicado: (2022)

Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest
por: Yin, Fufen, et al.
Publicado: (2019)

Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient
por: Tang, Jia, et al.
Publicado: (2019)

Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
por: Chen, Jialu, et al.
Publicado: (2022)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rs5b990aammou80tq1hdbfr9gb